0001213900-23-094145.txt : 20231207 0001213900-23-094145.hdr.sgml : 20231207 20231207181351 ACCESSION NUMBER: 0001213900-23-094145 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231205 FILED AS OF DATE: 20231207 DATE AS OF CHANGE: 20231207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weisblum Eric CENTRAL INDEX KEY: 0001569077 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41512 FILM NUMBER: 231473558 MAIL ADDRESS: STREET 1: 285 GRAND AVENUE CITY: ENGLEWOOD STATE: NJ ZIP: 07631 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Silo Pharma, Inc. CENTRAL INDEX KEY: 0001514183 STANDARD INDUSTRIAL CLASSIFICATION: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300] IRS NUMBER: 462137136 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 560 SYLVAN AVE STREET 2: SUITE 3160 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 BUSINESS PHONE: (718) 400-9031 MAIL ADDRESS: STREET 1: 560 SYLVAN AVE STREET 2: SUITE 3160 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 FORMER COMPANY: FORMER CONFORMED NAME: Uppercut Brands, Inc. DATE OF NAME CHANGE: 20190808 FORMER COMPANY: FORMER CONFORMED NAME: Point Capital, Inc. DATE OF NAME CHANGE: 20130130 FORMER COMPANY: FORMER CONFORMED NAME: Gold Swap Inc DATE OF NAME CHANGE: 20110301 4 1 ownership.xml X0508 4 2023-12-05 0 0001514183 Silo Pharma, Inc. SILO 0001569077 Weisblum Eric C/O SILO PHARMA, INC. 560 SYLVAN AVE., SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 1 1 0 0 CEO and President 0 Common Stock 2023-12-05 4 P 0 600 1.39 A 167724 D Common Stock 2023-12-06 4 P 0 76 1.34 A 167800 D Common Stock 2023-12-07 4 P 0 324 1.36 A 168124 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.40. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.34 to $1.40. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Eric Weisblum 2023-12-07